This guideline will inform physicians, nurses, dieticians, pharmacists, caregivers and other
home parenteral nutrition (HPN) providers, as well as healthcare administrators and policy …

Short bowel syndrome (SBS) is a rare malabsorptive disorder as a result of the loss of bowel
mass mostly secondary to surgical resection of the small intestine. Other causes are …

Background & aims In 2016, ESPEN published the guideline for Chronic Intestinal Failure
(CIF) in adults. An updated version of ESPEN guidelines on CIF due to benign disease in …

Background & aims Intestinal failure (IF) is defined as “the reduction of gut function below
the minimum necessary for the absorption of macronutrients and/or water and electrolytes …

Teduglutide has been described as an effective treatment for parenteral support (PS)
reduction in patients with short bowel syndrome (SBS). However, a quantitative summary of …

This guideline will inform physicians, nurses, dieticians, pharmacists, caregivers and other
home parenteral nutrition (HPN) providers, as well as healthcare administrators and policy …

Intestinal failure (IF) is the inability of the gut to absorb necessary water, macronutrients
(carbohydrate, protein, and fat), micronutrients, and electrolytes sufficient to sustain life and …

Intravenous supplementation (IVS) of parenteral nutrition (PN) admixtures and/or fluid and
electrolyte solutions is the primary treatment of intestinal failure (IF), defined as “the …

Background & aims Teduglutide, a GLP-2-analog, has proven effective in two placebo-
controlled studies in reducing parenteral support (PS) in patients with short bowel syndrome …

Short bowel syndrome (SBS) is a rare disorder with known physical, psychosocial, and
economic burdens and significant morbidity and mortality. Many individuals with SBS …